Depression during Pregnancy

Area of Science:

• Obstetrics and Gynecology
• Perinatal Psychiatry
• Developmental Pediatrics

Background:

• Pregnancy often involves women with active psychiatric conditions, with or without psychotropic medication.
• Untreated antenatal depression and stress are linked to adverse birth outcomes and child development.
• Antenatal exposure to antidepressant medications also presents potential risks to pregnancy and development.

Purpose of the Study:

• To review best practices for managing depression in pregnant women.
• To highlight the risks associated with untreated depression and antidepressant use during pregnancy.
• To provide recommendations for future research in perinatal mental health.

Main Methods:

• Systematic review of existing literature.
• Meta-analysis of relevant studies.
• Synthesis of current evidence on perinatal psychiatric care.

Main Results:

• Antidepressant use in pregnancy is associated with small increased risks of miscarriage, cardiac malformations, preterm birth, and persistent pulmonary hypertension of the newborn (PPHN).
• Transient neonatal symptoms occur in up to one-third of neonates exposed to antidepressants.
• There is a possible increased risk of delayed motor development in children exposed antenatally to antidepressants.

Conclusions:

• Current evidence provides minimal definitive conclusions to guide treatment recommendations for depression in pregnancy.
• Management strategies must weigh the risks of untreated maternal illness against potential medication side effects.
• Further research is crucial to establish clear guidelines for safe and effective perinatal mental health care.